Autoimmune Diseases  >>  Gamunex (intravenous normal human immunoglobulin 10%)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gamunex (intravenous normal human immunoglobulin 10%) / Bayer, Grifols, Kedrion
NCT00220740: Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Completed
3
117
US, Canada, Europe, RoW
Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified, IGIV-C, IGIV-Chromatography (IGIV-C), 10%, Gamunex®, Gaminex®, IGIVnex, Intravenous Immunoglobulin (Human) (IGIV), Intravenous Immunoglobulin (Human), IVIG, IGIV, Intravenous Immune Globulin (Human), TAL-05-00004, Bay 41-1000, NDC13533-645-12, NDC13533-645-15, NDC13533-645-20, NDC13533-645-71, NDC13533-645-24, Albumin (Human) 25%, United States Pharmacopeia (USP), Albumin (Human) 25%, USP, Plasbumin®-25, Plasbumin®-25 (Low Aluminum), TAL-05-00009, TAL-05-00025, Bay 34-9255, NDC 13533-684-16, NDC 13533-684-20, NDC 13533-684-71, NDC 13533-692-16, NDC 13533-692-20, NDC 13533-692-71
Grifols Therapeutics LLC
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
06/06
06/06

Download Options